HR 1316
115th Congress
House
Health
Administrative remedies
Consumer affairs
Contracts and agency
Government employee pay, benefits, personnel management
Health care costs and insurance
Health information and medical records
Insurance industry and regulation
Medical ethics
Medicare
Military medicine
Prescription drugs
Public contracts and procurement
Retail and wholesale trades
Right of privacy
Prescription Drug Price Transparency Act
Introduced: March 2, 2017
See on congress.gov
Everywhere this bill has been
5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 5, 2017
Referred to the Subcommittee on Military Personnel.
Mar 17, 2017
Referred to the Subcommittee on Health.
Mar 15, 2017
Referred to the Subcommittee on Health.
Mar 2, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 2, 2017
Introduced in House
Plain-English summary
Prescription Drug Price Transparency Act
This bill adds certain transparency requirements for pharmacy benefits managers under Medicare, Medicare Advantage, TRICARE, and the Federal Employees Health Benefits Program.
What's happening now
Referred to the Subcommittee on Military Personnel.